Dental Implants in Patients With End-Stage Renal Disease: A Case Series
Abstract
PURPOSE
Chronic kidney disease (CKD), a widespread health problem marked by a gradual loss of kidney function, presents unique challenges in various aspects of patient care. As such, this case series aimed to assess the feasibility of dental implants in end-stage renal disease (ESRD) patients.
MATERIALS AND METHODS
Parathyroid hormone (PTH) levels were measured at the time of implant placement and implant uncovering. Radiographic evaluations were performed at 7, 15, 30, 90, and 180 days after implant placement and 180 days after prosthetic rehabilitation. Bone remodeling was evaluated based on the values of radiographic marginal bone loss, measured as the distance between the implant shoulder and the marginal bone levels.
RESULTS
Fifteen patients with ESRD received a total of 27 implants (5 in the maxilla and 22 in the mandible) installed in different regions, with a diameter of 3.75 mm, height of 8.5 mm, platform of 4.1 mm, and Morse taper connection. No correlation was found between PTH levels and primary implant stability (ρ = 0.04, p value = 0.860). PTH levels ranged from 105.1 to 1965 pg/mL (mean 613.51 ± 494.38 pg/mL). Only one implant did not demonstrate primary stability during surgery, the others ranged from 15 to 50 Ncm of stability. Seven implants failed during the evaluation due to varying degrees of bone loss. There was no significant effect of primary stability or PTH levels on implant loss.
CONCLUSION
Accelerated marginal bone loss within 6 months and reduced…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.